Doshi, Peter

Neuraminidase inhibitors for preventing and treating influenza in adults and children

Jefferson, T., Jones, M. A., Doshi, P., Del Mar, C. B., Hama, R., Thompson, M. J., Spencer, E. A., Onakpoya, I. J., Mahtani, K. R., Nunan, D., et al. (2014) · Cochrane Database of Systematic Reviews

Influenza Virus Research StudiesRespiratory viral infections research

Cited by 382

Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults

Fraiman, J., Erviti, J., Jones, M., Greenland, S., Whelan, P., Kaplan, R. M., & Doshi, P. (2022) · Vaccine

SARS-CoV-2 and COVID-19 ResearchPharmacovigilance and Adverse Drug Reactions

Cited by 228

Will covid-19 vaccines save lives? Current trials aren’t designed to tell us

Doshi, P. (2020) · BMJ

SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancy

Cited by 150

Harms are assessed inconsistently and reported inadequately Part 2: nonsystematic adverse events

Mayo-Wilson, E., Fusco, N., Li, T., Hong, H., Canner, J. K., Dickersin, K., Bertizzolo, L., Cowley, T., Doshi, P., Ehmsen, J., et al. (2019) · Journal of Clinical Epidemiology

Pharmacovigilance and Adverse Drug ReactionsPharmaceutical industry and healthcare

Cited by 109

Cherry-picking by trialists and meta-analysts can drive conclusions about intervention efficacy

Mayo-Wilson, E., Li, T., Fusco, N., Bertizzolo, L., Canner, J. K., Cowley, T., Doshi, P., Ehmsen, J., Gresham, G., Guo, N., et al. (2017) · Journal of Clinical Epidemiology

Meta-analysis and systematic reviewsPharmaceutical industry and healthcare

Cited by 108

Harms are assessed inconsistently and reported inadequately part 1: systematic adverse events

Mayo-Wilson, E., Fusco, N., Li, T., Hong, H., Canner, J. K., Dickersin, K., Bertizzolo, L., Cowley, T., Doshi, P., Ehmsen, J., et al. (2019) · Journal of Clinical Epidemiology

Pharmacovigilance and Adverse Drug ReactionsPharmaceutical industry and healthcare

Cited by 63

Covid-19 vaccines and treatments: we must have raw data, now

Doshi, P., Godlee, F., & Abbasi, K. (2022) · BMJ

SARS-CoV-2 and COVID-19 ResearchAcademic Publishing and Open Access

Cited by 63

Transparency of COVID-19 vaccine trials: decisions without data

Tanveer, S., Rowhani-Farid, A., Hong, K., Jefferson, T., & Doshi, P. (2022) · BMJ Evidence-Based Medicine

SARS-CoV-2 and COVID-19 ResearchEthics in Clinical Research

Cited by 57

The use of clinical study reports to enhance the quality of systematic reviews: a survey of systematic review authors

Hodkinson, A., Dietz, K. C., Lefebvre, C., Golder, S., Jones, M., Doshi, P., Heneghan, C., Jefferson, T., Boutron, I., & Stewart, L. (2018) · Systematic Reviews

Meta-analysis and systematic reviewsPharmaceutical industry and healthcare

Cited by 49

Availability of study protocols for randomized trials published in high-impact medical journals: A cross-sectional analysis

Spence, O., Hong, K., Onwuchekwa Uba, R., & Doshi, P. (2020) · Clinical Trials

Meta-analysis and systematic reviewsAcademic Publishing and Open Access

Cited by 37